The mutation frequency of TP53 is different in different types of cancer, and the mutation frequency of solid tumors is higher than that of MNs including acute myeloid neoplasm (AML), myeloproliferative neoplasm (MPN), and myelodysplastic syndrome (MDS) (Zhao et al., 2024). Here, TP53 is linked to myeloproliferative disorder.